About RemotaHealth.AI

RemotaHealth.AI develops the m2-ICU, a Quiet ICU suite that utilizes real-time clinical intelligence for continuous patient monitoring and automated data analysis. This technology enhances critical care outcomes by providing healthcare professionals with actionable insights derived from real-time data, addressing the challenges of data overload and delayed decision-making in intensive care settings.

<problem> Intensive care units (ICUs) generate vast amounts of patient data, leading to information overload for healthcare professionals. Delayed decision-making due to the complexity of analyzing this data can negatively impact critical care outcomes. </problem> <solution> RemotaHealth.AI develops the m2-ICU, a system designed to provide real-time clinical intelligence for continuous patient monitoring and automated data analysis in the ICU. The m2-ICU aims to enhance critical care outcomes by delivering actionable insights derived from real-time data streams. By automating data analysis and providing timely alerts, the system helps healthcare professionals make more informed decisions, potentially improving patient outcomes and streamlining workflows. The system addresses the challenges of data overload and delayed decision-making in intensive care settings by providing a consolidated and intelligent view of patient status. </solution> <features> - Real-time clinical intelligence for continuous patient monitoring. - Automated data analysis to identify critical trends and anomalies. - Actionable insights delivered to healthcare professionals for timely intervention. </features> <target_audience> The primary target audience includes healthcare professionals working in intensive care units, such as intensivists, nurses, and hospital administrators. </target_audience>

What does RemotaHealth.AI do?

Where is RemotaHealth.AI located?

RemotaHealth.AI is based in Almè, Sweden.

When was RemotaHealth.AI founded?

RemotaHealth.AI was founded in 2023.

Location

Almè, Sweden

Founded

2023

Employees

2 employees

Looking for specific startups?

Try our free semantic startup search

RemotaHealth.AI

Score: 24/100

AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

asclep.io 100+

Founded 2023 – Almè, Sweden

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

No team information available. Click "Fetch founders" to run a focused founder search.

Company Description

Problem

Intensive care units (ICUs) generate vast amounts of patient data, leading to information overload for healthcare professionals. Delayed decision-making due to the complexity of analyzing this data can negatively impact critical care outcomes.

Solution

RemotaHealth.AI develops the m2-ICU, a system designed to provide real-time clinical intelligence for continuous patient monitoring and automated data analysis in the ICU. The m2-ICU aims to enhance critical care outcomes by delivering actionable insights derived from real-time data streams. By automating data analysis and providing timely alerts, the system helps healthcare professionals make more informed decisions, potentially improving patient outcomes and streamlining workflows. The system addresses the challenges of data overload and delayed decision-making in intensive care settings by providing a consolidated and intelligent view of patient status.

Features

Real-time clinical intelligence for continuous patient monitoring.

Automated data analysis to identify critical trends and anomalies.

Actionable insights delivered to healthcare professionals for timely intervention.

Target Audience

The primary target audience includes healthcare professionals working in intensive care units, such as intensivists, nurses, and hospital administrators.